• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Euroimmun 抗 SARS-CoV-2 IgG 检测试剂的实施和扩展评估及其对英国 COVID-19 公共卫生应对的贡献。

Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response.

机构信息

Diagnostic Support, Science Group, UK Health Security Agency, Porton, Porton Down, United Kingdom.

SARS-CoV-2 Serosurveillance Laboratory, UK Health Security Agency, Porton, Porton Down, United Kingdom.

出版信息

Microbiol Spectr. 2022 Feb 23;10(1):e0228921. doi: 10.1128/spectrum.02289-21.

DOI:10.1128/spectrum.02289-21
PMID:35196807
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8865481/
Abstract

In March 2020, the Rare and Imported Pathogens Laboratory at the UK Health Security Agency (UKHSA) (formerly Public Health England [PHE]) Porton Down, was tasked by the Department of Health and Social Care with setting up a national surveillance laboratory facility to study SARS-CoV-2 antibody responses and population-level sero-surveillance in response to the growing SARS-CoV-2 outbreak. In the following 12 months, the laboratory tested more than 160,000 samples, facilitating a wide range of research and informing UKHSA, DHSC, and UK government policy. Here we describe the implementation and use of the Euroimmun anti-SARS-CoV-2 IgG assay and provide an extended evaluation of its performance. We present a markedly improved overall sensitivity of 91.39% (≥14 days 92.74%, ≥21 days 93.59%) compared to our small-scale early study, and a specificity of 98.56%. In addition, we detail extended characteristics of the Euroimmun assay: intra- and interassay precision, correlation to neutralization, and assay linearity. Serology assays have been useful in determining those with previous SARS-CoV-2 infection in a wide range of research and serosurveillance projects. However, assays vary in their sensitivity at detecting SARS-CoV-2 antibodies. Here, we detail an extended evaluation and characterization of the Euroimmun anti-SARS-CoV-2 IgG assay, one that has been widely used within the United Kingdom on over 160,000 samples to date.

摘要

2020 年 3 月,英国卫生安全局(UKHSA)(前身为英国公共卫生署[PHE])波特兰唐恩的稀有和进口病原体实验室受卫生和社会保障部委托,建立了一个国家监测实验室设施,以研究 SARS-CoV-2 抗体反应和人群水平的血清学监测,以应对不断扩大的 SARS-CoV-2 疫情。在接下来的 12 个月里,该实验室测试了超过 16 万份样本,为广泛的研究提供了便利,并为 UKHSA、DHSC 和英国政府政策提供了信息。在这里,我们描述了 Euroimmun 抗 SARS-CoV-2 IgG 检测试剂盒的实施和使用情况,并对其性能进行了扩展评估。我们发现,与我们早期的小规模研究相比,该检测试剂盒的整体敏感性显著提高,达到 91.39%(≥14 天 92.74%,≥21 天 93.59%),特异性为 98.56%。此外,我们详细介绍了 Euroimmun 检测试剂盒的扩展特性:批内和批间精密度、与中和的相关性以及检测的线性。血清学检测在广泛的研究和血清学监测项目中,对于确定那些曾经感染过 SARS-CoV-2 的人非常有用。然而,检测试剂盒在检测 SARS-CoV-2 抗体的敏感性方面存在差异。在这里,我们详细介绍了 Euroimmun 抗 SARS-CoV-2 IgG 检测试剂盒的扩展评估和特征描述,该试剂盒迄今为止已在英国的 16 万多个样本中得到广泛应用。

相似文献

1
Implementation and Extended Evaluation of the Euroimmun Anti-SARS-CoV-2 IgG Assay and Its Contribution to the United Kingdom's COVID-19 Public Health Response.Euroimmun 抗 SARS-CoV-2 IgG 检测试剂的实施和扩展评估及其对英国 COVID-19 公共卫生应对的贡献。
Microbiol Spectr. 2022 Feb 23;10(1):e0228921. doi: 10.1128/spectrum.02289-21.
2
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.四种 SARS-CoV-2 抗体检测试剂在 COVID-19 患者及细菌性和非 SARS-CoV-2 病毒呼吸道感染患者中的诊断性能比较。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1983-1997. doi: 10.1007/s10096-021-04285-4. Epub 2021 Jun 9.
3
Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays.基于替代酶联免疫吸附试验的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)cPass 中和抗体检测分析的评估及其与免疫球蛋白 G 商业血清学分析的相关性。
Arch Pathol Lab Med. 2021 Oct 1;145(10):1212-1220. doi: 10.5858/arpa.2021-0213-SA.
4
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.五种市售血清学检测方法检测 SARS-CoV-2 抗体的性能比较及识别高中和抗体滴度个体。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02257-20.
5
Evaluation of 3 SARS-CoV-2 IgG Antibody Assays and Correlation with Neutralizing Antibodies.评估 3 种 SARS-CoV-2 IgG 抗体检测试剂盒与中和抗体的相关性。
J Appl Lab Med. 2021 Apr 29;6(3):614-624. doi: 10.1093/jalm/jfaa188.
6
A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays.跨国政府合作独立评估 SARS-CoV-2 血清学检测方法
Microbiol Spectr. 2022 Feb 23;10(1):e0156421. doi: 10.1128/spectrum.01564-21. Epub 2022 Jan 12.
7
Evaluation of Commercial Rapid Lateral Flow Tests, Alone or in Combination, for SARS-CoV-2 Antibody Testing.评估商业快速侧向流动检测,单独或联合使用,用于 SARS-CoV-2 抗体检测。
Am J Trop Med Hyg. 2021 Jun 28;105(2):378-386. doi: 10.4269/ajtmh.20-1390.
8
Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.血清学检测抗 SARS-CoV-2 抗体可提高 COVID-19 患者诊断的灵敏度。
Med Microbiol Immunol. 2021 Dec;210(5-6):283-289. doi: 10.1007/s00430-021-00721-6. Epub 2021 Sep 25.
9
Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population.在尼日利亚人群中验证商业 SARS-CoV-2 免疫测定。
Microbiol Spectr. 2021 Oct 31;9(2):e0068021. doi: 10.1128/Spectrum.00680-21. Epub 2021 Oct 6.
10
Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.评估针对 SARS-CoV-2 的 IgG 和中和抗体的免疫原性检测方法的稳健验证和性能比较。
PLoS One. 2022 Feb 7;17(2):e0262922. doi: 10.1371/journal.pone.0262922. eCollection 2022.

引用本文的文献

1
SCORE: Serologic evidence of COVID-19 and social and occupational contacts in healthcare workers in long-term care and acute care facilities in Southeastern Ontario (SCORE).SCORE:安大略省东南部长期护理和急症护理机构医护人员中COVID-19的血清学证据以及社交和职业接触情况(SCORE)。
PLoS One. 2025 Aug 13;20(8):e0303813. doi: 10.1371/journal.pone.0303813. eCollection 2025.
2
Revisiting the link between COVID-19 incidence and infection fatality rate during the first pandemic wave.重新审视第一波疫情期间新冠病毒感染率与感染死亡率之间的联系。
Sci Rep. 2025 May 5;15(1):15638. doi: 10.1038/s41598-025-99078-6.
3
Estimating SARS-CoV-2 infection probabilities with serological data and a Bayesian mixture model.

本文引用的文献

1
Comparability of six different immunoassays measuring SARS-CoV-2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction.六种不同免疫测定法检测 SARS-CoV-2 抗体与恢复期血浆中中和抗体水平的可比性:从效用到预测。
Transfusion. 2021 Oct;61(10):2837-2843. doi: 10.1111/trf.16600. Epub 2021 Aug 17.
2
Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK.英国伦敦献血者中 SARS-CoV-2 血清流行率及其在公共卫生和社会措施实施后的变化
Emerg Infect Dis. 2021 Jul;27(7):1795-1801. doi: 10.3201/eid2707.203167.
3
Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom.
利用血清学数据和贝叶斯混合模型估计新冠病毒感染概率。
Sci Rep. 2024 Apr 25;14(1):9503. doi: 10.1038/s41598-024-60060-3.
4
Immune response to vaccination in people with psychotic disorders relative to healthy controls: prospective study of SARS-CoV-2 vaccination.精神病患者与健康对照者对疫苗接种的免疫反应:SARS-CoV-2疫苗接种的前瞻性研究
BJPsych Open. 2024 Feb 16;10(2):e49. doi: 10.1192/bjo.2024.10.
对常规呼吸道样本的回顾性筛查发现,英国存在未被检测到的新冠病毒社区传播以及干预机会的错失。
J Gen Virol. 2021 Jun;102(6). doi: 10.1099/jgv.0.001595.
4
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.COVID-19 患者住院期间的恢复期血浆治疗(RECOVERY):一项随机对照、开放标签、平台试验。
Lancet. 2021 May 29;397(10289):2049-2059. doi: 10.1016/S0140-6736(21)00897-7. Epub 2021 May 14.
5
Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021.2021 年英格兰 COVID-19 疫苗接种计划对献血者血清阳性率的影响。
J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.04.037. Epub 2021 May 11.
6
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.英格兰医护人员的 COVID-19 疫苗接种率和 BNT162b2 mRNA 疫苗对感染的有效性(SIREN):一项前瞻性、多中心、队列研究。
Lancet. 2021 May 8;397(10286):1725-1735. doi: 10.1016/S0140-6736(21)00790-X. Epub 2021 Apr 23.
7
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers.SARS-CoV-2 的血清学监测:公共卫生工作者队列的六个月趋势和抗体反应。
J Infect. 2021 May;82(5):162-169. doi: 10.1016/j.jinf.2021.03.015. Epub 2021 Mar 22.
8
Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection.轻度SARS-CoV-2感染抗体反应中异质性和血清逆转的时间序列分析及机制建模
EBioMedicine. 2021 Mar;65:103259. doi: 10.1016/j.ebiom.2021.103259. Epub 2021 Mar 2.
9
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.既往感染过严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的个体对第一剂BNT162b2的抗体反应。
Lancet. 2021 Mar 20;397(10279):1057-1058. doi: 10.1016/S0140-6736(21)00501-8. Epub 2021 Feb 25.
10
Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19.医护人员生物资源:一项前瞻性医护人员队列研究的概述和基线特征,以研究新冠病毒病中的免疫保护和发病机制。
Wellcome Open Res. 2020 Oct 12;5:179. doi: 10.12688/wellcomeopenres.16051.2. eCollection 2020.